Clare Grace, Ph.D., Becomes Parexel’s First Chief Patient Officer

Parexel has appointed Clare Grace, Ph.D., to the newly-created Chief Patient Officer position. In this role, Clare will take ownership of global patient advocacy and site initiatives. Clare is a seasoned executive in the contract research organization (CRO) and biopharmaceutical industries with significant experience in patient and site-focused leadership. She was previously with Syneos Health Clinical Solutions, where she was Vice President of Site and Patient Access. Prior to that, she held several leadership roles with PPD, ultimately serving as Senior Director and Head of Global Site Intelligence. Her earlier career included leadership roles with AstraZeneca and Antisoma. Parexel is leading the charge as the first top-tier CRO company to have a Chief Patient Officer.

Parexel International is a contract research organization that provides biopharmaceutical services and conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. The company is headquartered near Boston, MA and in Durham, NC, with nearly 20,000 employees supporting clients in more than 100 countries.